Satellos Bioscience Inc.
MSLE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421642
No open-market purchases or sales by Satellos Bioscience Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $59.6M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Satellos Bioscience Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +31 vs. Q4 2025
- Shares held
- 7.60M
- +7.60M vs. Q4 2025
- Total value
- $42.8M
- +$42.8M vs. Q4 2025
- New holders
- 31
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MSLE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $59.6M |
| Q1 2026 | 31 | $45.9M |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Satellos Bioscience Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Franklin Resources Inc | 938,666 | $5.31M | 0.00% | +938,666 | New |
| Siren, L.L.C. | 892,074 | $5.02M | 0.14% | +892,074 | New |
| Vivo Capital, LLC | 813,666 | $4.58M | 0.38% | +813,666 | New |
| Point72 Asset Management, L.P. | 690,778 | $3.89M | 0.01% | +690,778 | New |
| Woodline Partners LP | 500,432 | $2.82M | 0.01% | +500,432 | New |
| Sphera Funds Management Ltd. | 489,207 | $2.75M | 0.47% | +489,207 | New |
| Suvretta Capital Management, LLC | 475,000 | $2.67M | 0.07% | +475,000 | New |
| Soleus Capital Management, L.P. | 414,359 | $2.33M | 0.09% | +414,359 | New |
| Avidity Partners Management LP | 387,769 | $2.18M | 0.44% | +387,769 | New |
| Adage Capital Partners GP, L.L.C. | 380,354 | $2.14M | 0.00% | +380,354 | New |
| Saturn V Capital Management LLC | 350,000 | $1.97M | 0.36% | +350,000 | New |
| Millennium Management LLC | 298,433 | $1.68M | 0.00% | +298,433 | New |
| 683 Capital Management, LLC | 230,833 | $1.30M | 0.12% | +230,833 | New |
| Empery Asset Management, LP | 230,100 | $1.30M | 1.56% | +230,100 | New |
| ADAR1 Capital Management, LLC | 222,555 | $1.25M | 0.08% | +222,555 | New |
| Stonepine Capital Management, LLC | 100,000 | $563.0K | 0.50% | +100,000 | New |
| Citadel Advisors LLC | 42,492 | $239.2K | 0.00% | +42,492 | New |
| HRT Financial LP | 30,461 | $171.0K | 0.00% | +30,461 | New |
| Morgan Stanley | 21,183 | $119.3K | 0.00% | +21,183 | New |
| Jane Street Group, LLC | 19,608 | $110.4K | 0.00% | +19,608 | New |
| Royal Bank of Canada | 16,245 | $91.0K | 0.00% | +16,245 | New |
| Monashee Investment Management LLC | 12,000 | $67.6K | 0.04% | +12,000 | New |
| Geode Capital Management, LLC | 11,907 | $67.0K | 0.00% | +11,907 | New |
| Propel Bio Management, LLC | 10,145 | $57.1K | 0.04% | +10,145 | New |
| Axq Capital, LP | 10,096 | $56.8K | 0.01% | +10,096 | New |
| China Universal Asset Management Co., Ltd. | 6,400 | $36.0K | 0.00% | +6,400 | New |
| National Bank of Canada | 2,115 | $11.8K | 0.00% | +2,115 | New |
| MAI Capital Management | 140 | $789 | 0.00% | +140 | New |
| UBS Group AG | 28 | $158 | 0.00% | +28 | New |
| Federation des caisses Desjardins du Quebec | 19 | $106 | 0.00% | +19 | New |
| Caitong International Asset Management Co., Ltd | 1 | $6 | 0.00% | +1 | New |